$2.420
-0.030 (-1.22%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
FATE 相似圖表分析預測
Alphio's FATE stock price prediction model matches the current Fate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.39 (-1.13%). The 1-week path is $2.43 (+0.30%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Fate Therapeutics Inc 股票嗎？
Fate Therapeutics Inc is a good buy right now due to its recent FDA clearance for the FT839 CAR T-cell product, which has the potential to significantly impact autoimmune disease treatment. The current price of $2.43 is well below the analyst price target of $4 from Jefferies and $7 from H.C. Wainwright, indicating substantial upside potential. Additionally, the stock has shown a year-to-date change of +146.35%, reflecting strong investor interest and confidence in its future prospects. However, the main risk is the negative earnings trend, with an EPS of -0.25 reported in the last quarter, which investors should monitor closely.
FATE 股價於 Thursday 收在 $2.42，此前下跌 -1.22%
Fate Therapeutics Inc (FATE) last closed at $2.42, losing -1.22%. These facts feed the 1-day and 1-week FATE price prediction above.
分析師一致預期
Fate Therapeutics Inc（FATE）：買進 6、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Fate Therapeutics Inc（FATE）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 FATE 最接近的股票，依相似度排序。
FATE 季節性分析
Historically the probability of a positive September return for FATE is 27.27%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
FATE 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Sep 2026 | $1.49 | $1.67 | $1.86 | -31.17% |
| Oct 2026 | $1.06 | $1.28 | $1.42 | -47.09% |
| Nov 2026 | $1.08 | $1.34 | $1.47 | -44.59% |
| Dec 2026 | $1.27 | $1.48 | $1.58 | -38.73% |
2026 年，Fate Therapeutics Inc（FATE）預計區間為 $1.06 至 $1.86。
Fate Therapeutics Inc 2026 年月度預測
2026 年 Sep，Fate Therapeutics Inc 預計均價 $1.67，最低 $1.49，最高 $1.86。
2026 年 Oct，Fate Therapeutics Inc 預計均價 $1.28，最低 $1.06，最高 $1.42。
2026 年 Nov，Fate Therapeutics Inc 預計均價 $1.34，最低 $1.08，最高 $1.47。
2026 年 Dec，Fate Therapeutics Inc 預計均價 $1.48，最低 $1.27，最高 $1.58。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。